Thyroshield
ThyroShield Potassium Iodide 130 mg Thyroid Support For Radiation Emergency Preparedness 120 Tablets
ThyroShield Potassium Iodide 130 mg Thyroid Support For Radiation Emergency Preparedness 120 Tablets
Couldn't load pickup availability
Product features
Product features
Materials and care
Materials and care
Potassium Iodide (130 mg per tablet). Other Ingredients: Microcrystalline Cellulose, Stearic Acid, Silicon Dioxide, Magnesium Stearate.
Share
- Directly Sourced From USA
- Premium Quality & Authenticity
- 7 Day Easy Return

Product Description
Shop authentic Thyroshield products — imported from the USA. Browse more vitamins & supplements at Rudra Retails.
FAQ
Q1. What is potassium iodide 130 mg used for?
Ans: Potassium iodide 130 mg is used as a thyroid blocking agent during nuclear or radiological emergencies. It saturates the thyroid gland with stable iodine, preventing it from absorbing harmful radioactive iodine and lowering the risk of thyroid injury.
Q2. How long do you take potassium iodide for radiation?
Ans: Potassium iodide should only be taken for a short period as directed by public health officials. Continuous daily usage is not recommended unless explicitly advised by emergency authorities during an ongoing exposure event.
Q3. Can children take ThyroShield Potassium Iodide tablets?
Ans: Yes, children can take potassium iodide, but the dosage must be scaled down according to their age and body weight. Consult official public health guidelines or a pediatrician for precise pediatric administration instructions.
Q4. Is ThyroShield available as an authentic USA import in India?
Ans: Yes, Rudra Retails sources ThyroShield directly from authorized suppliers in the USA. Indian consumers receive 100 percent authentic, sealed premium products imported directly to ensure safety and quality.
Q5. Are there any side effects or precautions for potassium iodide?
Ans: Individuals with pre existing thyroid conditions like multinodular goiter or known iodine allergies should consult a doctor before use. Infants under one month requires medical monitoring after administration to check for temporary hypothyroidism.